Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Narrative) (Details)

Notes Payable (Narrative) (Details)				3 Months Ended		6 Months Ended		12 Months Ended
Notes Payable (Narrative) (Details)	Jul. 01, 2016	Jun. 22, 2016 USD ($)	May 31, 2016 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Dec. 31, 2015 USD ($)	Aug. 01, 2016 USD ($)	Jun. 28, 2016	Apr. 07, 2016	May 31, 2015 USD ($)	May 15, 2015 USD ($)	Jul. 31, 2012 USD ($)
Debt Instrument [Line Items]
Compounded interest on notes payable				$ 352,000	$ 429,000	$ 1,176,931	$ 429,074
Notes payable				61,200,000		61,200,000
Change in fair value of financial instruments				1,469,928	(1,852,730)	2,595,287	(125,627)
Lymphoseek sales revenue				4,231,719	1,963,548	8,014,399	3,798,970	$ 10,300,000
Net interest expense				7,500,000	1,600,000	9,700,000	2,500,000
Interest expense recorded related to amortization				5,000	146,000	$ 77,964	358,924
R-NAV [Member]
Debt Instrument [Line Items]
Joint venture, effective date of termination						May 31, 2016
Remaining amount on promissory note forgiven			$ 333,333
Cardinal Health [Member]
Debt Instrument [Line Items]
Percentage of receivables due from customers										50.00%
Remaining percentage of receivables due from customers held in escrow account										50.00%
Subsequent Event [Member] \| Cardinal Health [Member]
Debt Instrument [Line Items]
Percentage of receivables due from customers									75.00%
Remaining percentage of receivables due from customers held in escrow account									25.00%
Percentage of receivables due from customers after reaching escrow account limit									100.00%
Subsequent Event [Member] \| Cardinal Health [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Escrow account threshold target amount									$ 1,000,000
Platinum Credit Facility [Member]
Debt Instrument [Line Items]
Maximum borrowing capacity, amount														$ 50,000,000
Current borrowing capacity														$ 35,000,000
Compounded interest on notes payable						$ 624,000
Debt instrument effective rate						In accordance with the terms of the Section 16(b) Settlement Agreement discussed in Note 15(c), Platinum agreed to forgive interest owed on the credit facility in an amount equal to 6%, effective July 1, 2016.
Notes payable				9,100,000		$ 9,100,000
Remaining borrowing capacity				27,300,000		27,300,000
Unused additional borrowing capacity				15,000,000		15,000,000
Platinum notes payable				417,000		417,000
Change in fair value of financial instruments				(1,500,000)	$ 1,900,000	(2,600,000)	$ 126,000
Estimated fair value				9,500,000		9,500,000
Platinum Credit Facility [Member] \| Subsequent Event [Member]
Debt Instrument [Line Items]
Percentage of interest forgiven on credit facility	6.00%
Capital Royalty Partners II LP [Member]
Debt Instrument [Line Items]
Compounded interest on notes payable						553,000
Notes payable				51,700,000		$ 51,700,000
Debt instrument face amount												$ 50,000,000
Debt instrument, unused borrowing capacity												$ 10,000,000
Payment terms						2 years
Debt discount related to lender fees and other costs													$ 2,200,000
End-of-term fee amount				1,000,000		$ 1,000,000							1,000,000
Minimum amount of yearly EBITDA required under agreement						5,000,000
Minimum sales revenue target						$ 22,500,000		11,000,000
Minimum sales revenue target in 2020													45,000,000
Cure right ratio						2.5
Liquidity minimum				$ 5,000,000		$ 5,000,000							$ 5,000,000
Debt instrument default interest rate percentage				18.00%		18.00%					18.00%
Reduced minimum sales revenue target in 2015								$ 10,000,000
Obligations under loan agreement due and payable			$ 56,157,240.69
Claims made from primary bank accounts on default		$ 4,100,000
Cash adjusted to collection of collateral, on claims of default		778,000				$ 778,000
Cash adjusted to prepayment premium, on claims of default		2,100,000				2,100,000
Cash adjusted to backend facility fee, on claims of default		1,000,000
Cash adjusted to principal balance of debt on default		$ 189,000
Notes payable, discounts				$ 2,000,000		2,000,000
Capital Royalty Partners II LP [Member] \| Accrued Liabilities and Other [Member]
Debt Instrument [Line Items]
Accrued interest				$ 2,300,000		$ 2,300,000